col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


224 Results       Page 1

 [1] 
Elsevier: Journal of Hepatology
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2023―Dec―16 SARS-CoV-2 anti-spike IgG antibodies are present in all liver transplant recipients after fifth vaccine dose Jenny J.H. Smeets, Hannah van Malenstein, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
2 [GO] 2023―Oct―19 Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and in liver transplant recipients Sam M. Murray, Elisa Pose, Melanie Wittner, Maria-Carlota Londoño, Golda Schaub, Jonathan Cook, Stavros Dimitriadis, Georgina Meacham, Sophie Irwin, Zixiang Lim, Paul Duengelhoef, Martina Sterneck, Ansgar W. Lohse, Valeria Perez, Palak Trivedi, Khush Bhandal, Ben Mullish, Pinelopi Manousou, Nicholas M. Provine, Emma Avitabile, Miles Carroll, Tom Tipton, Saoirse Healy, Patrizia Burra, Paul Klenerman, Susanna Dunachie, Barbara Kronsteiner, Agnieszka Katarzyna Maciola, Giulia Pasqual, Virginia Hernandez-Gea, Juan Carlos Garcia-Pagan, Pietro Lampertico, Massimo Iavarone, Pere Gines, Marc Lütgehetmann, Julian Schulze zur Wiesch, Francesco Paolo Russo, Eleanor Barnes, Thomas Marjot, Gary Middleton, Charlotte Gaskell, Daniel Rea, Sarah Pirrie, Sarah J. Bowden, Ann Pope, Ana Hughes, Molly Harrison, Amanda Kirkham, Lucinda Middleton, Faye Lowe, Sophia Magwaro, Pamela Kearns, Sean H. Lim, Michelle Willicombe, Maria Prendecki, Candice Clarke, Paige Mortimer, Stacey McIntyre, David Thomas, Alex Richter, Sally Al-Taei, Carl S. Goodyear, Stefan Siebert, Neil Basu, Ashley Gilmour, Iain B. McInnes, Andrew Tong, Kieran Woolcock, Faisal Basheer, Charles Crawley, Ram Malladi, Andrew King, Sophie Lockey, Ben Uttenthal, John A. Snowden, Rachael Selby, Kim Orchard, Thushan I. de Silva, Naomi Meardon, Sam Hansford, Gurjinder Sandhar, Peter Kelleher, Murali Kesavan, Celia Moore, Pinelopi Manousou, Gareth Hahn, Benjamin Mullish, Maria Atta, Sarah Gleeson, Liz Lightstone, Paul Martin, Stephen McAdoo, Tina Thomson, Mickey BC. Koh, Daniele Avenoso, Robin Sanderson, Claire Taylor, Khushpreet Bhandal, Diana Hall, Andrew Filer, Palak Trivedi, Gordon Cook, Erin Hurst, Amy Publicover, Katy Scouse, Paul Klenerman, Susanna J. Dunachie, Eleanor Barnes, Sam M. Murray, Zixiang Lim, Jack Satsangi, Sophie Irwin, Georgina Meacham, Thomas Marjot, Stavros Dimitriadis, Jem Chalk, Daniel Hanke, Josef Hanke, Saoirse Healy, Stephen Laidlaw, Stephanie Longet, Nicholas Provine, Sarah Thomas, Victoria Walker, Zay Win, Richard Beesley, Vicky Churchill, Holly Loughton, Elspeth Insch, Eilean MacDonald, Doreen Trown, Patricia Faria, Julie Chackathayil, Clare Hutchison, Deborah Richardson, Maxine Arnott, Louise Bennett, James Brock, Victora Keillor, Andrew Melville, Lisa Melville, Samantha Miller, Aurelie Najm, Caron Paterson, Lewis Rodgers, Matthew Rutherford, Suzann Rundell, Emily Smith, Lynn Stewart, Flavia Sunzini, Miles Carroll, Patrizia Burra, Francesco Paolo Russo, Paola Zanaga, Thomas Marjot, Sam M. Murray, Eleanor Barnes, Victoria Walker, Anthony Brown, Georgina Meacham, Sophie Irwin, Marc Lütgehetmann, Melanie Wittner, Golda Schaub, Paul Duengelhoef, Martina Sterneck, Ansgar W. Lohse, Julian Schulze zur Wiesch, Pietro Lampertico, Massimo Iavarone, Jonathan Cook, Maria-Carlota Londoño, Elisa Pose, Valeria Perez, Virginia Hernandez-Gea, Juan Carlos Garcia-Pagan, Pere Gines, Nicola van Berckel, Thushan I. de Silva, Sarah L. Rowland-Jones, Sian Faustini, Alex Richter, Susan L. Dobson, Shona C. Moore, Lance Turtle, Daniel G. Wootton, James E.D. Thaventhiran, Donal Skelly, Priyanka Abraham, Sandra Adele, Mohammad Ali, Eleanor Barnes, Anthony Brown, Miles Carroll, Christopher P. Conlon, Alexandra S. Deeks, Susanna Dunachie, John Frater, Lisa Frending, Siobhan Gardiner, Anni Jamsen, Paul Klenerman, Barbara Kronsteiner, Stephanie Longet, Tom Malone, Alexander J. Mentzer, Eloise Phillips, Patpong Rongkard, Lizzie Stafford, Sagida Bibi, Christina Dold, Teresa Lambe, Katie Jeffery, Christopher JA. Duncan, Rebecca P. Payne, Simon Travis, Sarah Foulkes, Victoria Hall, Susan Hopkins, Jasmin Islam, Ashley Otter
3 [GO] 2023―Jul―20 Hepatobiliary manifestations in pediatric COVID-19 Tetiana Stoieva, Olga Dzhagiashvili, Vira Dovzhyk
4 [GO] 2023―Jul―20 Epidemic within pandemic: alcohol-related hepatitis and COVID-19 Natalie Marlowe, David Lam, Suthat Liangpunsakul
5 [GO] 2023―Jul―20 COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022 Stylianos Tzedakis, Ortal Yzhaky Shapira, Michael Schwarzinger, Sandrine Katsahian, Andrea Lazzati, Anthony Dohan, Romain Coriat, Philippe Sogni, Stanislas Pol, David Fuks, Vincent Mallet
6 [GO] 2023―Jul―20 Racial disparities in COVID-19 clinical outcomes among patients with cirrhosis in North America and Europe-an international registry study Umar Hayat, Saba Afroz, Faisal Kamal, Muhammad Haseeb, Faisal Inayat, Muhammad Kamal, Andrew Moon
7 [GO] 2023―Jul―20 Two-year follow-up of liver grafts from COVID-19 donors Margherita Saracco, Donatella Cocchis, Francesco Tandoi, Federica Rigo, Renato Romagnoli, Silvia Martini
8 [GO] 2023―Jul―20 Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-world setting Christophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, Lamiae Grimaldi, Jean-Charles Duclos-Vallée
9 [GO] 2023―Jul―20 Liver Transplantation outcomes in patients following COVID-19 infection Dinesh Jothimani, Mullai Ezhili, Radhika Venugopal, Hemalatha Ramachandran, Sathish Srinivasan, Ramya Paramashivam, Mohamed Rela
10 [GO] 2023―Jul―20 The impact of Covid-19 on hepatocellular carcinoma screening in British Columbia Makuza Jean Damascene, Stanley Wong, Mawuena Binka, Maryam Darvishian, Dahn Jeong, Prince Adu, Georgine Cua, Amanda Yu, Hector Velasquez, Maria Alvarez, Sofia Bartlett, Eric Yoshida, Alnoor Ramji, Mel Krajden, Naveed Janjua
11 [GO] 2023―Jul―20 A large-scale, centralized viral hepatitis screening model in Hainan province of China during the COVID-19 pandemic Tao Wu, Biao Wu, Feng Lin, Jiao Wang, Jianzhi Zhao, Lan Chen, Jinjie Li
12 [GO] 2023―Jul―20 Exploring the impacts of the COVID-19 pandemic on access to HCV-related care and support: findings from a survey of people with lived experience of incarceration and/or substance use in British Columbia, Canada Terri Buller-Taylor, Georgine Cua, Dahn Jeong, Naveed Janjua, Mawuena Binka
13 [GO] 2023―Jul―20 Influence of the COVID-19 pandemic on liver cancer-related mortality in the United States Zhu Zhan, Dan Shi, Chengchen Zhang, Yujing Shi, Na Wu, Hong-Gang Ren, Hong Ren
14 [GO] 2023―Jul―20 Detrimental association between COVID-19 pandemic stages and alcoholic hepatitis admissions: a Canadian population-based study Abdel-Aziz Shaheen, Mark G. Swain, Mayur Brahmania, Juan G. Abraldes
15 [GO] 2023―Jul―20 COVID-19 vaccination alters NK cell dynamics and transiently reduces HBsAg titers among patients with chronic hepatitis B Hyunjae Shin, Ha Seok Lee, Ji Yun Noh, June-Young Koh, So-Young Kim, Jeayeon Park, Sungwon Chung, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jae-Hoon Ko, Kyong Ran Peck, Joon Young Song, Eui-Cheol Shin, Jeong-Hoon Lee
16 [GO] 2023―Jul―20 Long-term cellular immune response to COVID-19 vaccination in patients with chronic liver disease Mariana Moura Henrique, Carolina Santos Palma, André L. Simão, Ana Godinho-Santos, Miguel Cardoso, Diogo Fernandes, Sofia Carvalhana, Miguel Moura, João Gonçalves, Helena Cortez-Pinto, Rui E. Castro
17 [GO] 2023―Jul―20 Alkaline phosphatase on admission to the intensive care unit as a new early prognostic biomarker for the development of COVID-19-associated secondary sclerosing cholangitis Lea Aratari, Lea Krauß, Vlad Pavel, Alexander Mehrl, Arne Kandulski, Karsten Guelow, Martina Mueller-Schilling, Stephan Schmid
18 [GO] 2023―Jul―20 Clinical characteristics, hospitalization, and mortality outcomes of Coronavirus Disease 2019 in primary sclerosing cholangitis liver transplant patients Stela Celaj, Vibhu Chittajallu, Scott Martin, Jaime Perez, Emad Mansoor
19 [GO] 2023―Jul―20 Impact of coronavirus disease pandemic on hospitalizations due to chronic liver disease in Belgrade, Serbia Ivana Pantic, Nina Rajovic, Sofija Lugonja, Svetlana Miltenovic, Tamara Milovanovic
20 [GO] 2023―Jul―20 Efficacy and safety of vaccination againts SARS-CoV-2 in patients with vascular liver disease Valeria Perez-Campuzano, Rautou Pe, Thomas Marjot, Michael Praktiknjo, Edilmar Alvarado-Tapias, Laura Turco, Luis Ibañez, Carlos González-Alayón, angela puente, Elba Llop, Macarena Simón-Talero, Carmen Álvarez-Navascués, Thomas Reiberger, Xavier Verhelst, Luis Téllez, Lara Orts, Giuseppe Grassi, Anna Baiges, Payance Audrey, Jonel Trebicka, Càndid Villanueva, Maria Cristina Morelli, Sam Murray, Georgina Meacham, Marc Luetgehetmann, Julian Schulze zur Wiesch, Juan Carlos Garcia Pagan, Eleanor Barnes, Aurélie Plessier, Virginia Hernandez-Gea
21 [GO] 2023―Jul―20 Anti-hepatitis B surface antigen negativity can be a risk factor for SARS-CoV-2 infection in SARS-CoV-2 vaccinated healthcare workers Tomohide Kurahashi, Atsuishi Hosui, Naoki Hiramatsu
22 [GO] 2023―Jul―20 SARS-CoV-2 productively infects human hepatocytes and induces cell death Cho-Chin Cheng, Chunkyu Ko, Shubhankar Ambike, Julia Sacherl, Stoyan Velkov, Bo-Hung Liao, Romina Bester, Merve Gültan, Constanze Jakwerth, Carsten Schmidt-Weber, Joachim Bugert, Roman Wölfel, Vincent Grass, Sandra Essbauer, Oliver Keppler, Carolin Mogler, Florian Vondran, Andreas Pichlmair, Ulrike Protzer
23 [GO] 2023―Jul―20 Booster SARS-CoV-2 vaccination elicits robust antibody response to wild type but not Omicron subvariants BA.4/5 in patients with cirrhosis Qian Zhu, Lu Wang, Xiaoxiao Hu, Dejuan Xiang, Ming-Li Peng, Dachuan Cai, Xiaofeng Shi, Hong Ren
24 [GO] 2023―Jul―20 Hepatitis flare appeared to be more severe with poorer outcome in chronic hepatitis B patients with recent COVID vaccination during the COVID pandemic Jennifer Tai, Yen-Chun Liu, Rachel Wen-Juei Jeng, Rong-Nan Chien, Yun-Fan Liaw
25 [GO] 2023―Jul―20 Hepatic alterations in COVID-19: a comparative autopsy study Sigurd Lax, Kristijan Skok, Peter Zechner, Stephan Aberle, Ute Bargfrieder, Claudia Grosse, Helmut Salzer, Thomas Zlamal, Lisa Setaffy, Harald Kessler, Hans-Peter Dienes, Michael Trauner
26 [GO] 2023―Jul―20 Recent splanchnic vein thrombosis occurring during Sars-Cov-2 infection-The VALDIG study Pierre Deltenre, Payance Audrey, Laure Elkrief, Vincenzo La Mura, Artru Florent, Anna Baiges, Jean Paul Cervoni, Louise China, Isabelle Colle, Elise Lemaitre, Bogdan Procopet, Dietmar Schiller, Christophe Bureau, Odile Goria, Isabelle Ollivier-Hourmand, Alexandre Nuzzo, Pierre-Emmanuel Rautou, Aurélie Plessier
27 [GO] 2023―Jul―20 Pandemic preparedness and viral hepatitis-Global survey of hepatitis program managers and healthcare providers Nida Ali, John Ward, Neil Gupta, Lindsey Hiebert
28 [GO] 2023―Jul―01 The vaccine-response in patients with cirrhosis after COVID-19 vaccination: A systematic analysis of 168,245 cirrhotic patients Zheng Li, Yue Hu, Bingwen Zou
29 [GO] 2023―Jun―07 Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics Sarp Uzun, Carl Zinner, Amke C. Beenen, Ilaria Alborelli, Ewelina M. Bartoszek, Jason Yeung, Byron Calgua, Matthias Reinscheid, Peter Bonsert, Anna K. Stalder, Jasmine Haslbauer, Jürg Vosbeck, Luca Mazzucchelli, Tobias Hoffmann, Luigi M. Terracciano, Gregor Hutter, Michael Manz, Isabelle Panne, Tobias Böttler, Maike Hofmann, Bertram Bengsch, Markus H. Heim, Christine Bernsmeier, Sizun Jiang, Alexandar Tzankov, Benedetta Terziroli Beretta-Piccoli, Matthias S. Matter
30 [GO] 2023―Mar―09 The present evidence summary of SARS-CoV-2 vaccine-associated liver injury: A rapid systematic review Zheng Li, Yue Hu, Yunlan Jiang
31 [GO] 2023―Feb―18 Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients Hendrik Luxenburger, David B. Reeg, Julia Lang-Meli, Matthias Reinscheid, Miriam Eisner, Dominik Bettinger, Valerie Oberhardt, Elahe Salimi Alizei, Katharina Wild, Anne Graeser, Vivien Karl, Florian Emmerich, Florian Klein, Marcus Panning, Daniela Huzly, Bertram Bengsch, Tobias Boettler, Roland Elling, Robert Thimme, Maike Hofmann, Christoph Neumann-Haefelin
32 [GO] 2022―Dec―22 Liver Transplant for Alcohol-Associated Liver Disease Continues to Rise 2-Years into the COVID-19 Pandemic Especially Among Young Adults Brian P. Lee, Jennifer L. Dodge, Norah A. Terrault
33 [GO] 2022―Dec―09 More efforts to explore the association between cirrhosis and COVID-19 mortality, and the association between NAFLD and severe COVID-19 Zheng Li, Yue Hu, Qiang Li
34 [GO] 2022―Nov―29 Comment on: Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States Han Zhang, Yan Peng, Xiaowei Tang
35 [GO] 2022―Nov―06 Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination. Anand V. Kulkarni, Margarita Anders, Leyla Nazal, Ezequiel Ridruejo, Cumali Efe
36 [GO] 2022―Oct―26 NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis Ying Wang, Yadong Wang, Guangcai Duan, Haiyan Yang
37 [GO] 2022―Sep―28 Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis Binu V. John, Raphaella D. Ferreira, Akash Doshi, David E. Kaplan, Tamar H. Taddei, Seth A. Spector, Elizabeth Paulus, Yangyang Deng, Dustin Bastaich, Bassam Dahman
38 [GO] 2022―Sep―27 Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data Ying Wang, Mengke Hu, Haiyan Yang
39 [GO] 2022―Sep―05 The origin of severe hepatitis of unknown aetiology in children: SARS-CoV-2 or adenovirus? Hang Yi, Yiwen Lin, Bin Lu, Yousheng Mao
40 [GO] 2022―Aug―18 Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States Xu Gao, Fan Lv, Xinyuan He, Yunyu Zhao, Yi Liu, Jian Zu, Linda Henry, Jinhai Wang, Yee Hui Yeo, Fanpu Ji, Mindie H. Nguyen
41 [GO] 2022―Jul―20 Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, Luca S. Belli, Marina Berenguer, Maria Buti, Rajiv Jalan, Mario U. Mondelli, Richard Moreau, Daniel Shouval, Thomas Berg, Markus Cornberg
42 [GO] 2022―Jul―09 Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines Carlos King Ho Wong, Lung Yi Mak, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Celine Sze Ling Chui, Esther Wai Yin Chan, Wing Yiu Cheng, Franco Wing Tak Cheng, Man Fung Yuen, Ian Chi Kei Wong
43 [GO] 2022―Jul―08 Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Sung Hak Lee, Pil Soo Sung
44 [GO] 2022―Jul―04 SARS-CoV-2 induces pericyte procoagulant response associated with portal vein microthrombosis and intrapulmonary vascular dilations in fatal COVID-19 Alberto Lasagni, Massimiliano Cadamuro, Claudia Maria Radu, Arianna Calistri, Matteo Pilan, Clarissa Valle, Pietro Angelo Bonaffini, Adriana Vitiello, Sandro Sironi, Maria Grazia Alessio, Previtali Giulia, Michela Seghezzi, Andrea Gianatti, Mario Strazzabosco, Alastair J Strain, Elena Campello, Luca Spiezia, Giorgio Palu, Cristina Parolin, Aurelio Sonzogni, Paolo Simioni, Luca Fabris
45 [GO] 2022―Jul―04 Exposure to the SARS-CoV-2 spike protein in an in vitro model of steatosis enhances hepatocyte oxidative stress: implications for COVID-19 and accelerated disease progression Angus Jacobs, Katie Morgan, Steven Morley, Kay Samuel, Jonathan Fallowfield, Peter Hayes, John Plevris
46 [GO] 2022―Jul―04 Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) specific cellular and humoral immunity in Corovavirus Disease-2019 (COVID-19) convalescence after liver transplantation-a prospective six month follow-up Theresa Kirchner, Hagen Sauer, Sophia Heinrich, Agnes Bonifacius, Ruhl Louisa, Isabell Pink, Bastian Engel, Emily Saunders, Joerg Martens, Marius M. Hoeper, Rainer Blasczkyk, Heiner Wedemeyer, Elmar Jaeckel, Christine Falk, Britta Eiz-Vesper, Richard Taubert
47 [GO] 2022―Jul―04 TERN-101, a farnesoid X receptor agonist, demonstrated similar safety and efficacy in non-alcoholic steatohepatitis patients with coronavirus disease of 2019 (COVID-19) exposure compared to those with no COVID-19 exposure in phase 2a LIFT study Eric Lawitz, Rohit Loomba, Douglas Denham, Diana Chung, Erin Quirk, Lois Lee, Tonya Marmon, Kris Kowdley
48 [GO] 2022―Jul―04 Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients Maria Guarino, Ilaria Esposito, Giuseppe Portella, Valentina Cossiga, Ilaria Loperto, Luca Pignata, Raffaella Tortora, Maria Rosaria Attanasio, Michele Cennamo, Mario Capasso, Daniela Terracciano, Francesco Maria Cutolo, Alfonso Galeota Lanza, Raffaele Lieto, Sarah di Somma, Francesco Paolo Picciotto, Filomena Morisco
49 [GO] 2022―Jul―04 The impact of COVID-19 on the duration of the liver transplant process in patients presenting for inpatient liver transplant evaluation Katherine Cooper, Arslan Talat, Diana Liu, Alessandro Colletta, Deepika Devuni
50 [GO] 2022―Jul―04 Impact of COVID-19 on the liver transplant activity in the US: variation by the region, etiology, and cirrhosis complications Ashwani Singal, Yong-Fang Kuo, Paul Yien Kwo, Robert Wong
51 [GO] 2022―Jul―04 Effectiveness of a central monitoring system for the continuum of care of hepatitis C in Brazil during COVID-19 pandemic Paulo Bittencourt, Liana Codes, Maria Lucia Ferraz
52 [GO] 2022―Jul―04 Hepatitis C treatment during the COVID-19 pandemic has similar efficacy with less resource utilization: analysis from the British Columbia HCV network Shirley Jiang, Jeanette Feizi, Julia MacIsaac, Edward Tam, Hin HIn Ko, Alnoor Ramji
53 [GO] 2022―Jul―04 Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis Martina Perez, Ann Ma, Marta Cervera, Marta Carol, Ana Belén Rubio, Sara Martinez, Carlota Riba, Laura Napoleone, Jordi Gratacós-Gines, Anna Soria, Emma Avitabile, Octavi Bassegoda, Adria Juanola, Elisa Pose, Isabel Graupera, Pere Ginès, Núria Fabrellas
54 [GO] 2022―Jul―04 Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis Berta Cuyas, Anna Huerta, Maria Poca, Edilmar Alvarado-Tapias, Anna Brujats, Eva Roman, Carlos Guarner, Àngels Escorsell, German Soriano
55 [GO] 2022―Jul―04 COVID-19 positive donor for solid organ transplantation Maddalena Peghin, Paolo Antonio Grossi
56 [GO] 2022―Jul―04 New cases of Budd-Chiari syndrome and splanchnic vein thrombosis after COVID-19 vaccination-a vascular liver disease group (VALDIG) initiative Raoel Maan, Aurélie Plessier, Louise China, David Patch, Anna Baiges, Juan Carlos Garcia Pagan, Virginia Hernandez-Gea, Marie-Noëlle Hilleret, E.T.T.L. Tjwa, Ilias Kounis, Christophe Bureau, Baptiste Giguet, Alexandra Heurgue-Berlot, Isabelle Ollivier-Hourmand, Xavier Causse, Filipe Gaio Castro Nery, Mandy Lauw, Sarwa Darwish Murad
57 [GO] 2022―Jul―04 Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients Manuel Mendizabal, Nicolas Ducasa, Paula Benencio, Maria Margarita Anders, Fernando Cairo, Adriana Alter, Patricia Etcheves, Giampaolo Scarton, Mirna Biglione, Ezequiel Mauro
58 [GO] 2022―Jul―04 Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose. Elena Diago Sempere, Ana Matilla, Carlos Rodríguez, Christie Perelló, Beatriz Minguez, Maria Varela, Juan José Urquijo, Javier Ampuero, Janire Prieto, Laura Márquez Pérez, Javier Crespo, María Bermúdez, Ana Maria Piedra Cerezal, Moises Diago, Belén Ruiz Antoran, José Luis Calleja Panero
59 [GO] 2022―Jul―04 SARS-CoV-2 infection in liver transplant recipients-a single center case series from Romania Ioana-Alexandra Husar-Sburlan, Raluca Roxana Grigorescu, Elena Cristina Radu, Daniela Tabacelia, Madalina Florescu, Florina Nitu, Radu Dumitru, Ana Stanila, Alexandru Martiniuc, Nicolae Boleac, Dragos Chirita, Laura Popa-Dan, Cezar Stroescu, Narcis Copca
60 [GO] 2022―Jul―04 Liver transplant patients infection rate with SARS-CoV-2 is lower but depend upon the infection rate in the general population and have a better outcome Michal Cohen-Naftaly, Evelin Oxtrud, Orly Sneh Arbib, Assaf Issachar, Yael Harif, Amir Shlomai, Marius Braun
61 [GO] 2022―Jul―04 Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients Yana Davidov, Victoria Indenbaum, Michal Mandelboim, Keren Asraf, Tal Gonen, Keren Tsaraf, Oranit Cohen-Ezra, Mariya Likhter, Gil Ben Yaacov, Ital Nemet, Limor Kliker, Orna Mor, Ram Doolman, Carmit Cohen, Arnon Afek, Yitshak Kreiss, Gili Regev, Yaniv Lustig, Ziv Ben Ari
62 [GO] 2022―Jul―04 Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients Supachaya Sriphoosanaphan, Sirinporn Suksawatamnuay, Nunthiya Srisoonthorn, Nipaporn Siripon, Panarat Thaimai, Wanwisar Makhasen, Nawakodchamon Mungnamtrakul, Kessarin Thanapirom, Bunthoon Nonthasoot, Pokrath Hansasuta, Piyawat Komolmit
63 [GO] 2022―Jul―04 Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients Lucy Meunier, Mathilde Sanavio, Magdalena Meszaros, Stéphanie Faure, José Ursic Bedoya, Maxime Echenne, Antoine Debourdeau, Georges-Philippe Pageaux
64 [GO] 2022―Jul―04 SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine Joanna Raszeja-Wyszomirska, Maciej K. Janik, Maciej Wójcicki, Piotr Milkiewicz
65 [GO] 2022―Jul―04 Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW) Alessandra Mangia, Valeria Piazzolla, Maria Squillante, Giovanna Cocomazzi, Vito Ciciriello, Vincenzo Giambra, Nicola Serra
66 [GO] 2022―Jul―04 Long-lasting seropositivity after anti SARS-CoV-2 vaccination in pre liver transplant patients Alberto Calleri, Margherita Saracco, Renato Romagnoli, Silvia Martini
67 [GO] 2022―Jul―04 Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region Pietro Torre, Mario Masarone, Roberta Sciorio, Monica Annunziata, Roberta Coppola, Laura Staiano, Carmine Coppola, Marcello Persico
68 [GO] 2022―Jul―04 Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients Liane Rabinowich, Ayelet Grupper, Inbal Houri, Sharon Levy, Merav Ben-Yehoyada, Tami Halperin, Oren Shibolet, Helena Katzman
69 [GO] 2022―Jul―04 Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients Aitor Odriozola Herrán, María Del Barrio, Antonio Cuadrado, Jose Ignacio Fortea, Lidia Amigo, David San Segundo Arribas, María Rodríguez-Cundin, María Rebollo, Roberto Fernandez, Federico Castillo, María Achalandabaso, Juan Andrés Echeverri, Juan Carlos Rodríguez-San Juan, Marcos López-Hoyos, Juan Carlos Rodríguez Duque, Álex García Tellado, Javier Crespo, Emilio Fabrega
70 [GO] 2022―Jul―04 Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study Supachaya Sriphoosanaphan, Sirinporn Suksawatamnuay, Nunthiya Srisoonthorn, Nipaporn Siripon, Panarat Thaimai, Wanwisar Makhasen, Nawakodchamon Mungnamtrakul, Kessarin Thanapirom, Bunthoon Nonthasoot, Pokrath Hansasuta, Piyawat Komolmit
71 [GO] 2022―Jul―04 Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients? Ubaldo Visco Comandini, Marzia Montalbano, Raffaella Lionetti, Paola Piccolo, Daniela Nesticò, Silvia Meschi, Chiara Agrati, Chiara Taibi, Laura Vincenzi, Enrico Girardi, Giuseppe Maria Ettorre, Giampiero D’Offizi
72 [GO] 2022―Jul―04 Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap? Marzia Montalbano, Raffaella Lionetti, Ubaldo Visco Comandini, Silvia Meschi, Chiara Agrati, Federica Conte, Vincenzo Puro, Paola Piccolo, Giulia Matusali, Germana Grassi, Tiziana Mereu, Federica Angelone, Enrico Girardi, Giuseppe Maria Ettorre, Giampiero D’Offizi
73 [GO] 2022―Jul―04 Hepatitis C screening rates by age cohort 1945-1965 in a large community health system before, during and after the COVID pandemic David Bernstein, Nitzan Roth, Ben Da, Sanjaya Satapathy, Henry Bodenheimer, Christian Kuntzen, Tai PIng Lee
74 [GO] 2022―Jul―04 Reorganizing and simplifying HCV diagnosis and treatment in special populations during COVID pandemic and beyond Paolo Scivetti, Elisa Perfetti, Lorenzo Somaini, Sarah Vecchio, Antonio Panero, Paola Zaldera
75 [GO] 2022―Jul―04 The negative impact of the pandemic on hospital admissions, morbidity and 30-day mortality for acute cirrhosis decompensation: a tertiary care perspective Kohilan Gananandan, Alexandra Phillips, Anmol Chikhlia, Hannah Old, Niharika Thakur, Konstantin Kazankov, Raj Mookerjee, Sharmaine Jia Ying Sim
76 [GO] 2022―Jul―04 Ectopic fat deposition in the liver and pancreas and the presence of excess visceral adipose tissue significantly increase hospitalisation risk following COVID-19 Tom Waddell, Adriana Roca-Fernandez, John McGonigle, Arun Jandor, Valentina Carapella, Helena Thomaides-Brears, Andrea Dennis, John Michael Brady, Rajarshi Banerjee
77 [GO] 2022―Jul―04 A novel prognostic model including liver function parameters accurately predicts 30-day mortality in patients admitted with COVID-19 David Uihwan Lee, Jason Cohen, Gregory Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
78 [GO] 2022―Jul―04 The prognostic implications of liver function test abnormalities in patients admitted to hospital with COVID-19 Jason Cohen, David Uihwan Lee, Gregory Fan, David Hastie, Akaash Mittal, Khanh Le, Yeeun Jang, Sarav Daid, Raffi Karagozian, Raza Malik
79 [GO] 2022―Jul―04 Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study Peter Hunyady, Lea Streller, Darius Ruether, Sara Reinartz Groba, Dominik Bettinger, Daniel Fitting, Karim Hamesch, Jens Marquardt, Victoria Mücke, Fabian Finkelmeier, Asieb Sekandarzad, Tobias Wengenmayer, Ayoub Bounidane, Felicitas Weiss, Kai-Henrick Peiffer, Bernhard Schlevogt, Stefan Zeuzem, Oliver Waidmann, Marcus Hollenbach, Martha M Kirstein, Johannes Kluwe, Fabian Kütting, Marcus Mücke
80 [GO] 2022―Jul―04 Use of Tocilizumab in patients with stable chronic liver disease and severe COVID-19 for prevention of decompensated cirrhosis, a prospective, open-label, randomized controlled trial. Luis Alejandro Rosales Renteria, Hiram Jaramillo-Ramírez, Francisco Calderón-Mendieta, Jesús Camacho-Escobedo, José Manuel Avendaño-Reyes, Diana Laura López-Rubio, Adrián Sández Araiza, Gisel Estefania Reyes-Higuera, Dulce Renée Soto-González, Erikc Jesús Arzola-Renteria
81 [GO] 2022―Jul―04 Prognostic value of liver function test for COVID-19 hospitalized patients with respiratory disease Carlos Alventosa Mateu, Elena Guillen Botaya, Cecilia Albert-Antequera, Irene Perez Alvarez, Alejandro Fernandez Soro, Eva Sanchez Ramos, Salvador Benlloch, Juan Jose Urquijo Ponce, Francesc Puchades Gimeno, Francisco Sanz Herrero, Miguel García Deltoro, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Dolores Ocete Mochon, Concepcion Gimeno Cardona, Moises Diago
82 [GO] 2022―Jul―04 Assessment of COVID-19 impact and response on hepatitis B virus and hepatitis C virus prevention and treatment from nationwide survey in Japan Md Razeen Ashraf Hussain, Aya Sugiyama, Lindsey Hiebert, Serge Ouoba, Bunthen E, Ko Ko, Tomoyuki Akita, Shuichi Kaneko, Tatsuya Kanto, John Ward, Junko Tanaka
83 [GO] 2022―Jul―04 Renin/angiotensin system-coagulation-inflammation axis abnormalities: a possible explanation for susceptibility to severe COVID-19 in cirrhosis Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, David JM Bauer, Georg Semmler, Daniela Gompelmann, Thomas Szekeres, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger
84 [GO] 2022―Jul―04 COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry Jonathan Frederik Brozat, Frank Hanses, Martina Haselberger, Melanie Stecher, Michael Dreher, Lukas Tometten, Maria Madeleine Rüthrich, Janne Vehreschild, Christian Trautwein, Stefan Borgmann, Maria Vehreschild, Carolin E.M Jakob, Andreas Stallmach, Kai Wille, Kerstin Hellwig, Nora Isberner, Philipp Reuken, Fabian Geisler, Jacob Nattermann, Tony Bruns
85 [GO] 2022―Jul―04 The course of COVID-19 infection in patients with chronic hepatitis B and Delta Yavuz Emre Parlar, Onur Keskin, Beril Kirmizigul, Genco Gencdal, Mujdat Zeybel, Mesut Gumussoy, Ramazan Idilman, Cihan Yurdaydin
86 [GO] 2022―Jul―04 Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease Zobair Younossi, Yusuf Yılmaz, Mohamed El Kassas, Ajay Kumar Duseja, Saeed Sadiq Hamid, Gamal Esmat, Nahum Méndez-Sánchez, Wah-Kheong Chan, Ashwani Singal, Janus Ong, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
87 [GO] 2022―Jul―04 Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vincent Wai-Sun Wong
88 [GO] 2022―Jul―04 Hepatitis B birth dose coverage remains dramatically low in The Gambia and has been disrupted by the COVID-19 pandemic Gibril Ndow, Esu Ezeani, Cecile de Bezenac, Julien Randon-Furling, Umberto D’Alessandro, Yusuke Shimakawa, Maud Lemoine
89 [GO] 2022―Jul―04 Trends of alcohol-related liver disease hospitalisation during the COVID-19 pandemic Oyekoya Ayonrinde, Richard Goodheart
90 [GO] 2022―Jul―04 Progress in HCV screening in the national hepatitis C elimination program in Georgia during the COVID-19 pandemic, 2019-2021 Amiran Gamkrelidze, Alexander Turdziladze, Maia Tsreteli, Vladimer Getia, Ana Aslanikashvili, Tinatin Kuchuloria, Irina Tskhomelidze, Sophia Surguladze, Lia Gvinjilia, Senad Handanagic, Shaun Shadaker, Paige A Armstrong
91 [GO] 2022―Jul―04 The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada Naveed Janjua, Stanley Wong, Dahn Jeong, Mawuena Binka, Terri Buller-Tylor, Sofia Bartlett, Prince Adu, Hector Velasquez, Makuza Jean Damascene, Amanda Yu, Maria Alvarez, Jason Wong, Mel Krajden
92 [GO] 2022―Jul―04 COVID-19 pandemic impact on alcoholic hepatitis healthcare utilisation Leya Nedumannil, Sukhdeep Steven Cheema, Karl Vaz, Ronald Ma, Daryl Jones, Stephen Warrillow, Josephine Grace, Darren Wong, Matthew Choy
93 [GO] 2022―Jul―04 Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study Alexandra Frolkis, Meredith Borman, Matthew Sadler, Stephen Congly, Henry Nguyen, Samuel Lee, Mark G Swain, Kelly Burak, Carla Coffin, Alexander Aspinall, Laura Stanton, Abdel Aziz Shaheen
94 [GO] 2022―Jul―04 Enhancing the cascade of hepatitis C care in community-recruited high-risk people who inject drugs during the COVID-19 pandemic: the Alexandros program Vana Sypsa, Sotiris Roussos, Efrossini Tsirogianni, Despina Trafali, Dimitra Tsiagka, Athena Gavalaki, Zafiris Papanikolaou, Ioanna Papagiouvanni, Athena Tampaki, Dimitrios Paraskevis, George Kalamitsis, Ioannis Goulis, Angelos Hatzakis
95 [GO] 2022―Jul―04 Knowledge, attitude and practice regarding COVID-19 vaccination among HCV infected patients in Georgia Lasha Gulbiani, Tiko Kamkamidze, Ana Gamezardashvili, George Kamkamidze, Maia Butsashvili
96 [GO] 2022―Jul―04 Combined COVID-19 vaccination and HIV and hepatitis C virus screening intervention for high-risk populations at a mobile testing unit in Madrid, Spain Jorge Valencia, Pablo Ryan, Guillermo Cuevas, Julieta Domingorena, Álvaro Vicario, Marcela Villota-Rivas, Jeffrey Lazarus
97 [GO] 2022―Jul―04 COVID-19 vaccination in liver cirrhosis: safety and immune and clinical responses Maria Ines Canha, Mario Jorge Silva, Maria Azevedo Silva, Mara Costa, Rita Catarina Saraiva, André Ruge, Mariana Machado, Catarina Félix, Bárbara Morão, Pedro Narra Figueiredo, Milena Mendes, Carina Leal, Filipe Calinas
98 [GO] 2022―Jul―04 Autoimmune hepatitis diagnosed after COVID-19 vaccination. Results from the spanish registry for autoimmune and cholestatic hepatitis Ana Barreira, Mar Riveiro Barciela, Agustin Castiella, Álvaro Díaz-González, Maria Carlota Londoño, Indhira Perez Medrano, Judith Gómez-Camarero, Marta Casado, Carmen Del Pozo-Calzada, María Dolores Antón Conejero, Magdalena Salcedo
99 [GO] 2022―Jul―04 Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy Roberta D’Ambrosio, Giuliano Rizzardini, Massimo Puoti, Stefano Fagiuoli, Maria Paola Anolli, Claudia Gabiati, Federico D’Amico, Luisa Pasulo, Massimo Colombo, Pietro Lampertico
100 [GO] 2022―Jul―04 No effect of HBsAg positivity on antibody response after COVID-19 vaccine Ganbolor Jargalsaikhan, Enkhtuul Batbold, Delgersaikhan Zulkhuu, Oyungerel Lkhagva-Ochir, Uurtsaikh Baatarsuren, Myagmarjav B�azar, Khatanzul Ganbold, Sumiya Byambabaatar, Byambasuren Ochirsum, Munkhzaya Munkhbaatar, Purevjargal Bat-Ulzii, Bishguurmaa Renchindorj, Andreas Bungert, Naranbaatar Dashdorj, Katy Shaw-Saliba, Irini Sereti, Sally Hunsberger, Renee Ridzon, Naranjargal Dashdorj
101 [GO] 2022―Jul―04 Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine Anand Kulkarni, Sasikala Mitnala, Sowmya Iyengar, Shashidhar Jaggaiahgari, Baqar Gora, Hardik Rugwani, Mithun Sharma, Nagaraja Rao Padaki, Nageshwar Reddy
102 [GO] 2022―Jul―04 mRNA COVID-19 vaccine effectiveness in liver transplant patients Muhammad Khan, Kamran Mushtaq, Deema AlSoub, Hussam Almasri, Bisher Sawaf, Saad AlKaabi, Yasser Kamel
103 [GO] 2022―Jul―04 COVID-19 vaccine induced autoimmune hepatitis-a first case series from India Sowmya Iyengar, Anand Kulkarni, Goutham Reddy Katukuri, Mithun Sharma, Nageshwar Reddy, Nagaraja Rao Padaki
104 [GO] 2022―Jul―04 Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER) Greta Codoni, Maria Alejandra Gracia Villamil, Albert Stättermayer, Agustin Castiella, Christoph Schramm, Jan-Philipp Weltzsch, Marcial Sebode, Christine Bernsmeier, Wikrom Karnsakul, Ana Lleo, Tom Gevers, Limas Kupcinskas, Nélia Hernandez, Andreas Cerny, Michele Ghielmetti, Diego Vergani, Giorgina Mieli-Vergani, Jose Pinazo Bandera, Maria Isabel Lucena, Raul J. Andrade, Yoh Zen, Richard Taubert
105 [GO] 2022―Jul―04 Two different types of COVID-19 vaccines and serial liver biochemistries Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vincent Wai-Sun Wong
106 [GO] 2022―Jul―04 Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study André L. Simão, Carolina Santos Palma, Laura Izquierdo-Sánchez, Antonella Putignano, Ângela Carvalho-Gomes, Andreas Posch, Paola Zanaga, Irina Girleanu, Carlos Araújo, Degré Delphine, Thierry Gustot, Iván Sahuco, Elia Spagnolo, Sofia Carvalhana, Miguel Moura, Mariana Moura Henrique, Diogo A.E Fernandes, Francisco Marques, Jesus Maria Banales, Manuel Romero Gomez, Anca Trifan, Francesco Paolo Russo, Rudolf E. Stauber, Marina Berenguer, Christophe Moreno, João Gonçalves, Helena Cortez-Pinto, Rui Castro
107 [GO] 2022―Jul―04 Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis Binu John, Akash Doshi, Yangyang Deng, Natalie Mansour, A.Sidne Barritt, Andrew Moon, George Ioannou, Paul Martin, Hann-Hsiang Chao, Tamar H Taddei, David Kaplan, Bassam Dahman
108 [GO] 2022―Jul―04 Incidence, phenotype and prognostic relevance of COVID-19-related liver injury across different age strata Lukas Hartl, Katharina Haslinger, Martin Angerer, Mathias Jachs, Benedikt Simbrunner, David J.M Bauer, Bernhard Scheiner, Ernst Eigenbauer, Robert Strassl, Monika Breuer, Oliver Kimberger, Daniel Laxar, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
109 [GO] 2022―Jul―04 Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database Frank Tacke, Fady Tanios, Lin Xie, Deepa Malhotra, Simon Dagenais, Nino Katchiuri, Birol Emir
110 [GO] 2022―Jul―04 Cholangiopathy after severe COVID-19: what do we know so far? Valéria Ferreira de Almeida e Borges, Helma Pinchemel Cotrim, Marcelo Simão Ferreira, José Humberto Caetano Marins, Haroldo Luis Oliva Gomes Rocha, Leonardo Augusto Dias Nascimento, Mayra Machado Fleury Guedes, Julia Esteves Guerra
111 [GO] 2022―Jul―04 Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant Binu John, Raphaella Ferreira, Dustin Bastaich, Akash Doshi, Tamar H Taddei, David Kaplan, Seth Spector, Bassam Dahman
112 [GO] 2022―Jul―04 SARS-CoV-2 infection in patients with underlying chronic liver disease is associated with significantly greater risks of inpatient hospitalization, intensive care unit admission, and overall mortality Robert Wong, Yi Zhang, Mae Thamer
113 [GO] 2022―Jul―04 Humoral and cellular immunity after vaccination against SARS-CoV-2 is reduced in patients with chronic liver disease Al-Dury Samer, Johan Waern, Anna Martner, Hevar Hamah Saed, Marko Alavanja, Johan Ringlander, Andreas Törnell, Mohammad Arabpour, Jesper Waldenström, Hanna Grauers Wiktorin, Gisela Ringström, Martin Lagging
114 [GO] 2022―Jul―04 Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study Massimo Iavarone, Giulia Tosetti, Floriana Facchetti, Matilde Topa, Andrea Lombardi, Roberta D’Ambrosio, Elisabetta Degasperi, Alessandro Loglio, Chiara Oggioni, Alessandra Bandera, Andrea Gori, Ferruccio Ceriotti, Luigia Scudeller, Antonio Bertoletti, Pietro Lampertico
115 [GO] 2022―Jul―04 Post-COVID-19 cholangiopathy: does SARS-CoV-2 play a relevant role in histopathological findings? Valéria Ferreira de Almeida e Borges, Helma Pinchemel Cotrim, Marcelo Costa Silva, Liliana Sampaio Costa Mendes, Francisco Guilherme Cancela Penna, Antônio Ricardo Cardia Ferraz de Andrade, Frederico Chaves Salomão, Juliana Daud, Luiz Antônio Rodrigues de Freitas
116 [GO] 2022―Jul―04 The impact of liver fibrosis on the immune response to SARS-CoV-2 vaccination in metabolic associated fatty liver disease patients Marta Freitas, Tiago Capela, Vítor Macedo Silva, Sofia Xavier, Joana Teixeira Magalhães, Carla Maria Moura Marinho, José Cotter
117 [GO] 2022―Jul―04 Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study Kristin Jorgensen, Adity Chopra, Joseph Sexton, Anne T Tveter, Johannes R. Hov, Ingrid Jyssum, Lise Sofie H. Nissen-Meyer, John T Vaage, Silje W Syversen, Guro L Goll, Fridtjof Lund-Johansen, Jørgen Jahnsen
118 [GO] 2022―Jul―04 Evaluation of immune response and disease flares in metobolic-associated fatty liver disease patients following SARS-CoV-2 vaccination: a prospective cohort study Junping Shi, Qianru Zhu, Jin Gao, Jiaping Gu, Lu Shen, Jing Liu, Yu Song, Xiying Gong, Yutong Chen, Jie Liao, Yining He, Siyi Zhang, Li Shao, Yee Hui Yeo, Jie Li
119 [GO] 2022―Jul―04 Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis Apichat Kaewdech, Nawamin Pinpathomrat, Naichaya Chamroonkul, Teerha Piratvisuth, Pimsiri Sripongpun
120 [GO] 2022―Jul―04 Association between immunosuppressants and poor antibody responses to inactivated SARS-CoV-2 vaccines in patients with autoimmune liver diseases Hu Li, Yuting Wang, Ling Ao, Mingxia Ke, Zhi-wei Chen, Min Chen, Ming-Li Peng, Ning Ling, Peng Hu, Dachuan Cai, Dazhi Zhang, Hong Ren
121 [GO] 2022―Jul―04 Effects of SARS-CoV2 pandemic in a cohort of italian NAFLD patients Bernardo Stefanini, Simona Leoni, Roberta Capelli, Alice Secomandi, Luca Muratori, Fabio Piscaglia, Silvia Ferri
122 [GO] 2022―Jul―04 Lack of awareness of a NAFLD pandemic in a high risk group. Is it time to act in primary care? Maria Guerra Veloz, Kosh Agarwal, Marck Chamley, Saima Ajaz
123 [GO] 2022―Jul―04 Humoral and cellular immune responses to wild-type and omicron (B.1.1.529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and patients with autoimmune hepatitis Stavros Dimitriadis, Georgina Meacham, Sophie Irwin, Victoria Walker, Sam Murray, Zixiang Lim, Thomas Marjot, Jack Satsangi, Eleanor Barnes
124 [GO] 2022―Jul―04 T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network Sam Murray, Stephanie Longet, Tom Tipton, Maria Carlota Londoño, Elisa Pose, Stephen Laidlaw, Dung Nguyen, Georgina Meacham, Zixiang Lim, Stavros Dimitriadis, Sophie Irwin, Jonathan Cook, Massimo Iavarone, Pietro Lampertico, Virginia Hernandez-Gea, Juan Carlos Garcia Pagan, Julian Schulze zur Wiesch, Martina Sterneck, Francesco Paolo Russo, Jack Satsangi, Susanna Dunachie, Paul Klenerman, Carl Goodyear, Iain B. McInnes, Pere Ginès, Miles Carroll, Thomas Marjot, Eleanor Barnes
125 [GO] 2022―Jul―04 Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study Thomas Marjot, Sam Murray, Elisa Pose, Zixiang Lim, Maria Carlota Londoño, Melanie Wittner, Marc Luetgehetmann, Virginia Hernandez-Gea, Juan Carlos Garcia Pagan, Golda Schaub, Paul Duengelhoef, Martina Sterneck, Ansgar W. Lohse, Palak Trivedi, Khushpreet Bhandal, Benjamin H. Mullish, Pinelopi Manousou, Patrizia Burra, Floriana Facchetti, Susan L. Dobson, Alexandra S. Deeks, Lance Turtle, Paul Klenerman, Susanna Dunachie, Pere Ginès, Massimo Iavarone, Julian Schulze zur Wiesch, Francesco Paolo Russo, Eleanor Barnes
126 [GO] 2022―May―16 Exacerbation of Familial Intrahepatic Cholestasis in Conjunction with COVID-19 Vaccination Yakir Guri, Jürg Vosbeck, Michael Dickenmann, Alexander Jetter, Christine Bernsmeier
127 [GO] 2022―Apr―21 SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis Tobias Boettler, Benedikt Csernalabics, Henrike Salié, Hendrik Luxenburger, Lara Wischer, Elahe Salimi Alizei, Katharina Zoldan, Laurenz Krimmel, Peter Bronsert, Marius Schwabenland, Marco Prinz, Carolin Mogler, Christoph Neumann-Haefelin, Robert Thimme, Maike Hofmann, Bertram Bengsch
128 [GO] 2022―Mar―10 Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients Pierluigi Toniutto, Edmondo Falleti, Sara Cmet, Annarosa Cussigh, Laura Veneto, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, Carlo Fabris, Assunta Sartor, Roberto Peressutti, Francesco Curcio, Laura Regattin, Lucrezia Grillone
129 [GO] 2022―Mar―10 Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care Darius Ferenc Rüther, Jan Philipp Weltzsch, Christoph Schramm, Marcial Sebode, Ansgar Wilhelm Lohse
130 [GO] 2022―Mar―10 Unexplained liver test elevations after SARS-CoV-2 vaccination John Guardiola, Craig Lammert, Evgenia Teal, Naga Chalasani
131 [GO] 2021―Nov―25 Prono-SARS: Prognosis of French COVID-19 Patients in 2020-2021 François Depret, Samir Bouam, Michaël Schwarzinger, Vincent Mallet
132 [GO] 2021―Nov―20 Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease Dong Liu, Qianlong Zhang, Pinqing Bai, Jian Zhao
133 [GO] 2021―Oct―14 Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS) Francesco Paolo Russo, Manhal Izzy, Ashwin Rammohan, Varvara A. Kirchner, Tommaso Di Maira, Luca Saverio Belli, Thomas Berg, Marina Carmen Berenguer, Wojciech Grzegorz Polak
134 [GO] 2021―Oct―09 Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: time for comprehensive data analysis Liane Rabinowich, Oren Shibolet, Helena Katchman
135 [GO] 2021―Oct―02 Reply Prognosis of Covid-19 patients with chronic liver disease in France in 2020 Vincent Mallet, Michaël Schwarzinger, Vincent Mallet, Michaël Schwarzinger, Nathanaël Beeker, Samir Bouam, Hélène Fontaine;, Marion Corouge;, Anaïs Vallet Pichard, Clémence Hollande, Philippe Sogni, Stanislas Pol
136 [GO] 2021―Sep―30 Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: a case control study from the prospective COVID-ICU database Mikhael Giabicani, Alice Le Menestrel, Olivier Roux, Pierre-Emmanuel Rautou, Emmanuel Weiss
137 [GO] 2021―Aug―26 Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases Paul J. Thuluvath, Polly Robarts, Mahak Chauhan
138 [GO] 2021―Aug―25 New-Onset Autoimmune Hepatitis following mRNA Covid-19 Vaccination in a 36-year-old woman with Primary Sclerosing Cholangitis - should we be more vigilant? Taotao Zhou, Florian Fronhoffs, Leona Dold, Christian P. Strassburg, Tobias J. Weismüller
139 [GO] 2021―Aug―24 Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk? Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza
140 [GO] 2021―Aug―10 Autoimmune Hepatitis Developing After Coronavirus Disease 2019 (COVID-19) Vaccine: One or Even Several Swallows Do Not Make a Summer Bril Fernando
141 [GO] 2021―Aug―03 Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open! Maria Guarino, Valentina Cossiga, Ilaria Esposito, Furno Alessandro, Filomena Morisco
142 [GO] 2021―Jul―31 Liver injury following SARS-CoV-2 vaccination: a multicenter case series Hersh Shroff, Sanjaya K. Satapathy, James M. Crawford, Nancy J. Todd, Lisa B. VanWagner
143 [GO] 2021―Jul―19 Association of chronic liver disease with the prognosis of COVID-19 patients Junyu Long, Xinting Sang, Haitao Zhao
144 [GO] 2021―Jul―17 SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis Theresa Kirchner, Elmar Jaeckel, Christine S. Falk, Britta Eiz-Vesper, Richard Taubert
145 [GO] 2021―Jul―15 Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury Antonio Saviano, Thomas F. Baumert
146 [GO] 2021―Jul―10 AN ANUSUAL CASE OF ACUTE CHOLESTATIC HEPATITIS AFTER m-RNABNT162b2 (COMIRNATY) SARS-CoV-2 VACCINE: COINCIDENCE, AUTOIMMUNITY OR DRUG RELATED LIVER INJURY? Francesca Lodato, Anna Larocca, Antonietta D’Errico, Vincenzo Cennamo
147 [GO] 2021―Jul―08 The mRNA COVID-19 vaccine - a rare trigger of Autoimmune Hepatitis? Cathy McShane, Clifford Kiat, Jonathan Rigby, Órla Crosbie
148 [GO] 2021―Jun―24 Intravenous ketamine is a risk factor for jaundice in Covid-19 patients Vincent Mallet, Vincent Mallet, Kilian Bock, Mourad Dellagi, Marion Tano, Virginie Siorat, Nathanaël Beeker, Pascal Paubel, Paul Doumbe Mandengue, Nicolas Dufour, Torsten Voigtländer, Jean-Damien Ricard, Pierre Isnard, Vincent Frochot, Emmanuel Letavernier, Lucile Moga, Amandine Landrieux, Pierre-Emmanuel Rautou, Nathalie Pons-Kerjean, Anaïs Vallet-Pichard, Clémence Hollande, Hélène Fontaine, Laurent Chouchana, Coralie Gernez, Carole Burger, Anne Scemla, Christian de Tymowski, François Depret, Emmanuel Dudoignon, Lionel Lamhaut, Rémi Flicoteau, Géraldine Rousseau, Jean-Paul Duong Van Huyen, Jean-Michel Correas, Heiner Wedemeyer, Stanislas Pol
149 [GO] 2021―Jun―22 Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?” Daniel Clayton-Chubb, Daniel Schneider, Elliot Freeman, William Kemp, Stuart K. Roberts
150 [GO] 2021―Jun―18 Autoimmune hepatitis following COVID-19 Vaccination: true causality or mere association? Chin Kimg Tan, Yu Jun Wong, Lai Mun Wang, Tiing Leong Ang, Rahul Kumar
151 [GO] 2021―Jun―17 Response to letter to the editor by Capecchi et al. “Comment to the letter of Bril F et al. “Autoimmune Hepatitis Developing After Coronavirus Disease 2019 (COVID-19) Vaccine: Causality or Casualty?” Fernando Bril, David M. Fettig
152 [GO] 2021―Jun―12 Another case of autoimmune hepatitis after SARS-CoV-2 vaccination. Still casualty? Maria-Carlota Londoño, Jordi Gratacós-Ginès, Joaquín Sáez-Peñataro
153 [GO] 2021―Jun―09 Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty Alba Rocco, Costantino Sgamato, Debora Compare, Gerardo Nardone
154 [GO] 2021―Jun―06 Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19 Ze-yang Ding, Gan-xun Li, Chang Shu, Ping Yin, Bixiang Zhang
155 [GO] 2021―May―28 High acceptance rate of COVID-19 vaccination in liver transplant recipients Edoardo G. Giannini, Simona Marenco
156 [GO] 2021―May―25 Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients Markus Cornberg, Christiane S. Eberhardt
157 [GO] 2021―May―14 Prognosis of French COVID-19 patients with chronic liver disease: a national retrospective cohort study for 2020 Vincent Mallet, Nathanael Beeker, Samir Bouam, Philippe Sogni, Stanislas Pol, Vincent Mallet, Nathanaël Beeker, Samir Bouam, Hélène Fontaine;, Marion Corouge;, Anaïs Vallet Pichard, Clémence Hollande, Loriane Lair Mehiri, Philippe Sogni, Stanislas Pol
158 [GO] 2021―May―13 Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy Matthew J. McConnell, Nao Kawaguchi, Reiichiro Kondo, Aurelio Sonzogni, Lisa Licini, Clarissa Valle, Pietro A. Bonaffini, Sandro Sironi, Maria Grazia Alessio, Giulia Previtali, Michela Seghezzi, Xuchen Zhang, Alfred Lee, Alexander B. Pine, Hyung J. Chun, Xinbo Zhang, Carlos Fernandez-Hernando, Hua Qing, Andrew Wang, Christina Price, Zhaoli Sun, Teruo Utsumi, John Hwa, Mario Strazzabosco, Yasuko Iwakiri
159 [GO] 2021―May―07 HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination? Javier Crespo, Álvaro Díaz-González, Joaquín Cabezas
160 [GO] 2021―May―05 Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Stefano Brillanti
161 [GO] 2021―Apr―24 Risk stratification in hospitalized COVID-19 patients Angela Horvath, Theresa Lind, Natalie Frece, Herbert Wurzer, Vanessa Stadlbauer
162 [GO] 2021―Apr―24 Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study Jitao Wang, Zhiyun Hou, Jianxin Liu, Ye Gu, Yunhong Wu, Zhenhuai Chen, Jiansong Ji, Shiqi Diao, Yuanwang Qiu, Shengqiang Zou, Aiguo Zhang, Nina Zhang, Fengxian Wang, Xue Li, Yan Wang, Xing Liu, Cheng Lv, Shubo Chen, Dengxiang Liu, Xiaolin Ji, Chao Liu, Tao Ren, Jingwei Sun, Zhongwei Zhao, Fazong Wu, Fenxiang Li, Ruixu Wang, Yan Yan, Shiliang Zhang, Guohong Ge, Jiangbo Shao, Shiying Yang, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Jingwen Ai, Qing He, Ming-Hua Zheng, Liting Zhang, Qing Xie, Don C. Rockey, Jonathan A. Fallowfield, Wenhong Zhang, Xiaolong Qi
163 [GO] 2021―Apr―24 Letter regarding “association of liver abnormalities with in-hospital mortality in patients with COVID-19 Meng-Si Luo, Guan-Jiang Huang
164 [GO] 2021―Apr―21 Reply to: Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients Manuel Rodríguez-Perálvarez, Jordi Colmenero, Magdalena Salcedo
165 [GO] 2021―Apr―21 Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty? Fernando Bril, Sameer Al Diffalha, Mark Dean, David M. Fettig
166 [GO] 2021―Apr―21 Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients Liane Rabinowich, Ayelet Grupper, Roni Baruch, Merav Ben-Yehoyada, Tami Halperin, Dan Turner, Eugene Katchman, Sharon Levi, Inbal Houri, Nir Lubezky, Oren Shibolet, Helena Katchman
167 [GO] 2021―Apr―20 DECREASE IN VIRAL HEPATITIS DIAGNOSES DURING THE COVID-19 PANDEMIC IN THE NETHERLANDS Milan J. Sonneveld, Irene K. Veldhuijzen, Thijs van de Laar, Eline L.M. Op de Coul, Adriaan J. van der Meer
168 [GO] 2021―Mar―20 Liver Injury in COVID-19 - The culprit may not be COVID-19! Aditya Singh, Madhumita Premkumar, Virendra Singh
169 [GO] 2021―Mar―20 Progressive cholangiopathy in Covid-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered Pierre Deltenre, Christophe Moreno, Eric Trépo
170 [GO] 2021―Mar―20 Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C screening in Spain, in Europe, around the world Javier Crespo, Jeffrey V. Lazarus, Paula Iruzubieta, Federico García, Javier García-Samaniego
171 [GO] 2021―Feb―21 Intravenous ketamine and progressive cholangiopathy in Covid-19 patients Vincent Mallet
172 [GO] 2021―Feb―21 PRIMARY BILIARY CHOLANGITIS ASSOCIATED WITH SARS-COV2 INFECTION Alessandra Bartoli, Stefano Gitto, Pamela Sighinolfi, Carmela Cursaro, Pietro Andreone
173 [GO] 2021―Feb―07 EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients Markus Cornberg, Maria Buti, Christiane S. Eberhardt, Paolo Antonio Grossi, Daniel Shouval
174 [GO] 2021―Feb―06 Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. Gwilym J. Webb, Andrew M. Moon, Eleanor Barnes, A. Sidney Barritt, Thomas Marjot
175 [GO] 2021―Jan―26 SARS-CoV-2 infection in patients with autoimmune hepatitis Thomas Marjot, Gustav Buescher, Marcial Sebode, Eleanor Barnes, Alfred S. Barritt, Matthew J. Armstrong, Luke Baldelli, James Kennedy, Carolyn Mercer, Ann-Kathrin Ozga, Christian Casar, Christoph Schramm, Andrew M. Moon, Gwilym J. Webb, Ansgar W. Lohse
176 [GO] 2021―Jan―13 Detecting HCV infection by means of mass population SARS-CoV-2 screening: a pilot experience in Northern Italy Andrea Giacomelli, Gabriele Pagani, Federico Conti, Cinzia Bassoli, Massimo Galli
177 [GO] 2020―Dec―20 Impact of the COVID 19 Pandemic on HCV Elimination in Spain Maria Buti, Raquel Domínguez-Hernández, Miguel Angel Casado
178 [GO] 2020―Dec―19 Association of liver abnormalities with in-hospital mortality in patients with COVID-19 Ze-yang Ding, Gan-xun Li, Lin Chen, Chang Shu, Jia Song, Wei Wang, Yu-wei Wang, Qian Chen, Guan-nan Jin, Tong-tong Liu, Jun-nan Liang, Peng Zhu, Wei Zhu, Yong Li, Bin-hao Zhang, Huan Feng, Wan-guang Zhang, Zhen-yu Yin, Wen-kui Yu, Yang Yang, Hua-qiu Zhang, Zhou-ping Tang, Hui Wang, Jun-bo Hu, Ji-hong Liu, Ping Yin, Xiao-ping Chen, Bixiang Zhang
179 [GO] 2020―Dec―16 Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD Abraham S. Meijnikman, Sjoerd Bruin, Albert K. Groen, Max Nieuwdorp, Hilde Herrema
180 [GO] 2020―Nov―20 NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues Kamran Mushtaq, Muhammad Umair Khan, Fatima Iqbal, Deema Hussam Alsoub, Hammad Shabir Chaudhry, Fateen Ata, Phool Iqbal, Khaled Elfert, Girisha Balaraju, Muna Almaslamani, Khalid Al-Ejji, Saad AlKaabi, Yasser Medhat Kamel
181 [GO] 2020―Oct―30 Reply to: ‘NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression-The debate continues’ Dong Ji, Gregory Cheng, George Lau
182 [GO] 2020―Oct―20 Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points Marcos F. Fondevila, Maria Mercado-Gómez, Amaia Rodríguez, Maria J. Gonzalez-Rellan, Paula Iruzubieta, Víctor Valentí, Javier Escalada, Markus Schwaninger, Vincent Prevot, Carlos Dieguez, Javier Crespo, Gema Frühbeck, Maria L. Martinez- Chantar, Ruben Nogueiras
183 [GO] 2020―Oct―09 SARS-CoV-2 massive testing: a window of opportunity to catch up with HCV elimination Javier Crespo, Álvaro Díaz-González, Paula Iruzubieta, Susana Llerena, Joaquín Cabezas
184 [GO] 2020―Oct―08 COVID-19: discovery, diagnostics and drug development Tarik Asselah, David Durantel, Eric Pasmant, George Lau, Raymond F. Schinazi
185 [GO] 2020―Oct―06 Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study Thomas Marjot, Andrew M. Moon, Jonathan A. Cook, Sherief Abd-Elsalam, Costica Aloman, Matthew J. Armstrong, Elisa Pose, Erica J. Brenner, Tamsin Cargill, Maria-Andreea Catana, Renumathy Dhanasekaran, Ahad Eshraghian, Ignacio García-Juárez, Upkar S. Gill, Patricia D. Jones, James Kennedy, Aileen Marshall, Charmaine Matthews, George Mells, Carolyn Mercer, Ponni V. Perumalswami, Emma Avitabile, Xialong Qi, Feng Su, Nneka N. Ufere, Yu Jun Wong, Ming-Hua Zheng, Eleanor Barnes, Alfred S. Barritt, Gwilym J. Webb
186 [GO] 2020―Sep―16 Dried blood spots are a useful tool for hepatitis A screening in the pandemic areas with medical resource-limited condition Chikako Yamamoto, Junko Tanaka, Vichit Ork, Shintaro Nagashima, Channarena Chuon, Ko Ko, Mao Bunsoth, Md. Shafiqul Hossain
187 [GO] 2020―Sep―10 Health status of patients with Autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders (Belgium) Xavier Verhelst, Nicky Somers, Anja Geerts, Helena Degroote, Hans Van Vlierberghe
188 [GO] 2020―Sep―02 Covid-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall Alexandre Balaphas, Kyriaki Gkoufa, Jeremy Meyer, Andrea Peloso, Aurélie Bornand, Thomas A. McKee, Christian Toso, Sotirios-Georgios Popeskou
189 [GO] 2020―Aug―07 Authors’ reply on HIGH RATES OF 30-DAY MORTALITY IN PATIENTS WITH CIRRHOSIS AND COVID-19 Massimo Iavarone, Roberta D’Ambrosio, Pietro Lampertico
190 [GO] 2020―Aug―07 Impact of COVID-19 on global hepatitis C elimination efforts Sarah Blach, Loreta A. Kondili, Alessio Aghemo, Zongzhen Cai, Ellen Dugan, Chris Estes, Ivane Gamkrelidze, Siya Ma, Jean Michel Pawlotsky, Devin Razavi-Shearer, Homie Razavi, Imam Waked, Stefan Zeuzem, Antonio Craxi
191 [GO] 2020―Aug―01 Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients. Jordi Colmenero, Manuel Rodríguez-Perálvarez, Magdalena Salcedo, Ana Arias-Milla, Alejandro Muñoz-Serrano, Javier Graus, Javier Nuño, Mikel Gastaca, Javier Bustamante-Schneider, Alba Cachero, Laura Lladó, Aránzazu Caballero, Ainhoa Fernández-Yunquera, Carmelo Loinaz, Inmaculada Fernández, Constantino Fondevilla, Miquel Navasa, Mercedes Iñarrairaegui, Lluis Castells, Sonia Pascual, Pablo Ramírez, Carmen Vinaixa, María Luisa González-Dieguez, Rocío González-Grande, Loreto Hierro, Flor Nogueras, Alejandra Otero, José María Álamo, Gerardo Blanco-Fernández, Emilio Fábrega, Fernando García-Pajares, José Luis Montero, Santiago Tomé, Gloria De la Rosa, José Antonio Pons
192 [GO] 2020―Jul―27 Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination Jeffrey V. Lazarus, Camila A. Picchio, Shevanthi Nayagam, Scott Ratzan, Mark Thursz
193 [GO] 2020―Jul―13 SARS-CoV2 in patients on antiviral HBV and HCV therapy in Spain Sabela Lens, Mireia Miquel, Beatriz Mateos-Muñoz, Javier García-Samaniego, Xavier Forns
194 [GO] 2020―Jul―06 Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients Alexander Kroemer, Khalid Khan, Matthew Plassmeyer, Oral Alpan, M.A. Haseeb, Raavi Gupta, Thomas M. Fishbein
195 [GO] 2020―Jul―04 Reply to “Liver tests abnormalities in COVID-19: trick or treat?” Qingxian Cai, Lin Xu, Jun Chen
196 [GO] 2020―Jun―23 Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis Montserrat Fraga, Darius Moradpour, Florent Artru, Elodie Romailler, Jonathan Tschopp, Antoine Schneider, Haithem Chtioui, Marguerite Neerman-Arbez, Alessandro Casini, Lorenzo Alberio, Christine Sempoux
197 [GO] 2020―Jun―23 SARS-CoV-2 infection in liver-Author’s reply Yijin Wang, Fengmin Lu, Jingmin Zhao
198 [GO] 2020―Jun―20 Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis? Gabriella Assante, Roger Williams, Neil Alexander Youngson
199 [GO] 2020―Jun―20 The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research Feng Gao, Zhi-Ming Huang
200 [GO] 2020―Jun―20 Characteristics of pregnant COVID-19 patients with liver injury Guangtong Deng, Furong Zeng, Lijuan Zhang, Hui Chen, Xiang Chen, Mingzhu Yin
201 [GO] 2020―Jun―20 Letter regarding [High rates of 30-day mortality in patients with cirrhosis and COVID-19] Mohammed A. Medhat, Mohamed El Kassas
202 [GO] 2020―Jun―15 COVID-19 and Liver. Dinesh Jothimani, Radhika Venugopal, Mohammed Forhad Abedin, Ilankumaran Kaliamoorthy, Mohamed Rela
203 [GO] 2020―Jun―09 High rates of 30-day mortality in patients with cirrhosis and COVID-19 Massimo Iavarone, Roberta D’Ambrosio, Alessandro Soria, Michela Triolo, Nicola Pugliese, Paolo Del Poggio, Giovanni Perricone, Sara Massironi, Angiola Spinetti, Elisabetta Buscarini, Mauro Viganò, Canio Carriero, Stefano Fagiuoli, Alessio Aghemo, Luca S. Belli, Martina Lucà, Marianna Pedaci, Alessandro Rimondi, Maria Grazia Rumi, Pietro Invernizzi, Paolo Bonfanti, Pietro Lampertico
204 [GO] 2020―Jun―02 SARS-CoV-2: is the liver merely a bystander to severe disease? Mansoor N. Bangash, Jaimin M. Patel, Dhruv Parekh, Nicholas Murphy, Rachel M. Brown, Ahmed M. Elsharkawy, Gautam Mehta, Matthew J. Armstrong, Desley Neil
205 [GO] 2020―May―28 Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2 Vincent De Smet, Stefaan Verhulst, Leo A. van Grunsven
206 [GO] 2020―May―27 Liver tests abnormalities in COVID-19: trick or treat? Edoardo Vespa, Nicola Pugliese, Daniele Piovani, Antonio Capogreco, Silvio Danese, Alessio Aghemo
207 [GO] 2020―May―23 SARS-CoV-2 related liver impairment - perception may not be the reality Cyriac Abby Philips, Rizwan Ahamed, Philip Augustine
208 [GO] 2020―May―23 An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise Claire Alexandra Chew, Shridhar Ganpathi Iyer, Alfred Wei Chieh Kow, Krishnakumar Madhavan, Andrea Sze Teng Wong, Karim J. Halazun, Narendra Battula, Irene Scalera, Roberta Angelico, Sharid Farid, Bettina M. Buchholz, Fernando Rotellar, Albert Chi-Yan Chan, Jong Man Kim, Chih-Chi Wang, Maheswaran Pitchaimuthu, Mettu Srinivas Reddy, Arvinder Singh Soin, Carlos Derosas, Oscar Imventarza, John Isaac, Paolo Muiesan, Darius F. Mirza, Glenn Kunnath Bonney
209 [GO] 2020―May―22 A Local Response to COVID-19 for Advanced Liver Disease: Current Model of Care, Challenges and Opportunities Marina Serper, Abraham Shaked, Kim M. Olthoff, Maarouf Hoteit, Brenda Appolo, K. Rajender Reddy
210 [GO] 2020―May―21 High Mortality Rates for SARS-CoV-2 Infection in Patients with Pre-existing Chronic Liver Disease and Cirrhosis: Preliminary Results from an International Registry Andrew M. Moon, Gwilym J. Webb, Costica Aloman, Matthew J. Armstrong, Tamsin Cargill, Renumathy Dhanasekaran, Joan Genescà, Upkar S. Gill, Theodore W. James, Patricia D. Jones, Aileen Marshall, George Mells, Ponni V. Perumalswami, Xiaolong Qi, Feng Su, Nneka N. Ufere, Eleanor Barnes, A Sidney Barritt, Thomas Marjot
211 [GO] 2020―May―20 Lack of genetic evidence that fatty liver disease predisposes to COVID-19 Luca Valenti, Oveis Jamialahmadi, Stefano Romeo
212 [GO] 2020―May―12 Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy Angelo Di Giorgio, Emanuele Nicastro, Camilla Speziani, Massimo De Giorgio, Luisa Pasulo, Bianca Magro, Stefano Fagiuoli, Lorenzo D' Antiga
213 [GO] 2020―May―11 SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 Yijin Wang, Shuhong Liu, Hongyang Liu, Wei Li, Fang Lin, Lina Jiang, Xi Li, Pengfei Xu, Lixin Zhang, Lihua Zhao, Yun Cao, Jiarui Kang, Jianfa Yang, Ling Li, Xiaoyan Liu, Yan Li, Ruifang Nie, Jinsong Mu, Fengmin Lu, Shousong Zhao, Jiangyang Lu, Jingmin Zhao
214 [GO] 2020―May―11 Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’ Dong Ji, Enqiang Qin, George Lau
215 [GO] 2020―May―06 Reply to “Clinical characteristics of COVID-19 patients with abnormal liver tests” Qingxian Cai, Jun Chen
216 [GO] 2020―May―06 Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease’ Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau
217 [GO] 2020―Apr―30 No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease Louise Biquard, Dominique Valla, Pierre-Emmanuel Rautou
218 [GO] 2020―Apr―27 Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis Yu-Jie Zhou, Kenneth I. Zheng, Xiao-Bo Wang, Hua-Dong Yan, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Hong-Lei Ma, Yong-Ping Chen, Jacob George, Ming-Hua Zheng
219 [GO] 2020―Apr―27 Clinical characteristics of COVID-19 patients with abnormal liver tests Peng Chen, Benhong Zhou
220 [GO] 2020―Apr―17 Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury Xiaolong Qi, Chuan Liu, Zicheng Jiang, Ye Gu, Guo Zhang, Chuxiao Shao, Hongmei Yue, Zhenhuai Chen, Baoyi Ma, Dengxiang Liu, Lin Zhang, Jitao Wang, Dan Xu, Junqiang Lei, Xun Li, Huihong Huang, Yan Wang, Hongyan Liu, Jie Yang, Hongqiu Pan, Weiying Liu, Wenjuan Wang, Fujian Li, Shengqiang Zou, Hongguang Zhang, Jiahong Dong
221 [GO] 2020―Apr―14 COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care Elliot B. Tapper, Sumeet K. Asrani
222 [GO] 2020―Apr―14 Characteristics of Liver Tests in COVID-19 Patients Qingxian Cai, Deliang Huang, Hong Yu, Zhibin Zhu, Zhang Xia, Yinan Su, Zhiwei Li, Guangde Zhou, Jizhou Gou, Jiuxin Qu, Yan Sun, Yingxia Liu, Qing He, Jun Chen, Lei Liu, Lin Xu
223 [GO] 2020―Apr―10 Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia Ana Lleo, Pietro Invernizzi, Ansgar W. Lohse, Alessio Aghemo, Marco Carbone
224 [GO] 2020―Apr―08 Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau
 [1] 

224 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec